Arvinas (ARVN) Depreciation and Depletion (2017 - 2025)
Arvinas (ARVN) recorded quarterly Depreciation and Depletion of $700000.0 in Q1 2025, down 41.67% quarter-over-quarter from $1.2 million in Q1 2024, and down 41.67% on a YoY basis from $1.2 million in Q1 2024.
Arvinas (ARVN) Depreciation and Depletion (2017 - 2025) Analysis & Trends
Arvinas' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $700000.0 for Q1 2025.
- In Q1 2025, Depreciation and Depletion fell 41.67% year-over-year to $700000.0; the TTM figure through Mar 2025 stood at $2.4 million (up 27.33% YoY), while the FY2024 annual figure was $4.6 million, down 4.17% from the prior year.
- Depreciation and Depletion was $700000.0 for Q1 2025 at Arvinas, down from $1.2 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $1.2 million in Q1 2024 to a low of $700000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2019 | 246,158.00 |
| Mar 31, 2019 | 246,158.00 |
| Dec 31, 2018 | 222,948.00 |
| Dec 31, 2018 | 222,948.00 |
| Sep 30, 2018 | 191,547.00 |
| Sep 30, 2018 | 191,547.00 |
| Mar 31, 2018 | 123,028.00 |
| Mar 31, 2018 | 123,028.00 |
| Dec 31, 2017 | 101,028.00 |
| Dec 31, 2017 | 101,028.00 |
| Sep 30, 2017 | 92,147.00 |
| Sep 30, 2017 | 92,147.00 |